Andrew Kruegel is a medicinal chemist and pharmacologist who has focused on drug design and preclinical development for psychiatric treatment. He has also developed expertise in business operations, fundraising, and intellectual property strategy.
Intro paths
YC
Andrew went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
→
In turn, Andrew can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 2
Co-founders
JONATHAN SPORN· FounderDalibor Sames· FounderJonathan Sporn· Founder & CEO